Identification Of Fgfr2/3 Fusions From Clinical Cfdna Ngs Using A De Novo Fusion Caller.

Arielle Yablonovitch,Sante Gnerre,Lesli Ann Kiedrowski,Jennifer Yen,Leo Liu,Elena Helman,Stephen R Fairclough,Rebecca Nagy,Darya Chudova,AmirAli Talasaz

JOURNAL OF CLINICAL ONCOLOGY（2020）

引用 4|浏览60

暂无评分

摘要

3545Background: FGFR2/3 rearrangements are promising therapeutic targets, especially in advanced urothelial cancer (aUC) with FDA-approved erdafitinib. Liquid biopsy is an attractive non-invasive m...

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要